Gut microbiome: A possible common therapeutic target for treatment of atherosclerosis and cancer
- 28 June 2020
- journal article
- research article
- Published by Elsevier BV in Seminars in Cancer Biology
- Vol. 70, 85-97
- https://doi.org/10.1016/j.semcancer.2020.06.017
Abstract
No abstract availableKeywords
Funding Information
- Russian Science Foundation (18-15-00254)
This publication has 147 references indexed in Scilit:
- Intestinal microbiota metabolism of l-carnitine, a nutrient in red meat, promotes atherosclerosisNature Medicine, 2013
- Diversity, stability and resilience of the human gut microbiotaNature, 2012
- Structure, function and diversity of the healthy human microbiomeNature, 2012
- Variation of glucoraphanin metabolismin vivoandex vivoby human gut bacteriaBritish Journal of Nutrition, 2011
- Type 2 diabetes increases and metformin reduces total, colorectal, liver and pancreatic cancer incidences in Taiwanese: a representative population prospective cohort study of 800,000 individualsBMC Cancer, 2011
- Alleviating Cancer Drug Toxicity by Inhibiting a Bacterial EnzymeScience, 2010
- The Effect of Diet on the Human Gut Microbiome: A Metagenomic Analysis in Humanized Gnotobiotic MiceScience Translational Medicine, 2009
- AMP kinase/cyclooxygenase-2 pathway regulates proliferation and apoptosis of cancer cells treated with quercetinExperimental & Molecular Medicine, 2009
- Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive ProteinThe New England Journal of Medicine, 2008
- Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-γNature, 2004